Skip to main content
. 2020 May 31;32(10):e13914. doi: 10.1111/nmo.13914

Table 3.

The improvement in QoL based on IBDQ

Treatment Disease No of. patients IBDQ (T0/T1) median Adj.P
B CD T0 vs CD T1 7 173/191 1
B UC TO vs UC T1 14 170/193.5 .0284*
PBO CD T0 vs CD T1 12 174.5/179.5 .2364
PBO UC T0 vs UC T1 16 188/188 .5432

Abbreviations: B, treatment with butyrose; PBO, no treatment.

*

High significance.